Recombinant Human Growth Hormone and Rosiglitazone for Abdominal Fat Accumulation in HIV-Infected Patients with Insulin Resistance: A Randomized, Double-Blind, Placebo-Controlled, Factorial Trial

BACKGROUND: Recombinant human growth hormone (rhGH) reduces visceral adipose tissue (VAT) volume in HIV-infected patients but can worsen glucose homeostasis and lipoatrophy. We aimed to determine if adding rosiglitazone to rhGH would abrogate the adverse effects of rhGH on insulin sensitivity (SI) a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Glesby, Marshall J., Albu, Jeanine, Chiu, Ya-Lin, Ham, Kirsis, Engelson, Ellen, He, Qing, Muthukrishnan, Varalakshmi, Ginsberg, Henry N., Donovan, Daniel, Ernst, Jerry, Lesser, Martin, Kotler, Donald P.
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2013
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3625151/
https://ncbi.nlm.nih.gov/pubmed/23593417
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0061160
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados